Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wiesner

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|June 5, 2020
Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patientsA Reymundo, A Fernáldez-Bernáldez, A Reolid, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 4, 2017
Double-Strand DNA Breaks Induced by Paracyclophane Gold(I) ComplexesSebastian Bestgen, Carmen Seidl, Thomas Wiesner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Toward an improved definition of the tumor spectrum associated with BAP1 germline mutationsThomas Wiesner, Isabella Fried, Peter Ulz, et al.
Journal of the American Academy of Dermatology|January 18, 2014
Clinicopathologic and molecular features in cutaneous extranodal natural killer-/T-cell lymphoma, nasal type, with aggressive and indolent courseIsabella Fried, Monika Artl, Carlo Cota, et al.
The American Journal of Surgical Pathology|April 8, 2014
Ambiguous melanocytic tumors with loss of 3p21Iwei Yeh, Thaddeus W Mully, Thomas Wiesner, et al.
The American Journal of Surgical Pathology|February 13, 2016
Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional InitiationKlaus J Busam, Ricardo E Vilain, Trina Lum, et al.
Journal of Market Access & Health Policy|March 12, 2021
An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER)Rebecca Dean, Ivar Jensen, Phil Cyr, et al.
Nature|March 26, 2015
Therapy-induced tumour secretomes promote resistance and tumour progressionAnna C Obenauf, Yilong Zou, Andrew L Ji, et al.
Ocular Oncology and Pathology|May 31, 2016
Investigation of Somatic GNAQ, GNA11, BAP1 and SF3B1 Mutations in Ophthalmic MelanocytomasJasmine H Francis, Thomas Wiesner, Tatyana Milman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2017
Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profilesKlaus G Griewank, Thomas Wiesner, Rajmohan Murali, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of the European Academy of Dermatology and Venereology : JEADV|June 5, 2020
Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patientsA Reymundo, A Fernáldez-Bernáldez, A Reolid, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 4, 2017
Double-Strand DNA Breaks Induced by Paracyclophane Gold(I) ComplexesSebastian Bestgen, Carmen Seidl, Thomas Wiesner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Toward an improved definition of the tumor spectrum associated with BAP1 germline mutationsThomas Wiesner, Isabella Fried, Peter Ulz, et al.
Journal of the American Academy of Dermatology|January 18, 2014
Clinicopathologic and molecular features in cutaneous extranodal natural killer-/T-cell lymphoma, nasal type, with aggressive and indolent courseIsabella Fried, Monika Artl, Carlo Cota, et al.
The American Journal of Surgical Pathology|April 8, 2014
Ambiguous melanocytic tumors with loss of 3p21Iwei Yeh, Thaddeus W Mully, Thomas Wiesner, et al.
The American Journal of Surgical Pathology|February 13, 2016
Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional InitiationKlaus J Busam, Ricardo E Vilain, Trina Lum, et al.
Journal of Market Access & Health Policy|March 12, 2021
An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER)Rebecca Dean, Ivar Jensen, Phil Cyr, et al.
Nature|March 26, 2015
Therapy-induced tumour secretomes promote resistance and tumour progressionAnna C Obenauf, Yilong Zou, Andrew L Ji, et al.
Ocular Oncology and Pathology|May 31, 2016
Investigation of Somatic GNAQ, GNA11, BAP1 and SF3B1 Mutations in Ophthalmic MelanocytomasJasmine H Francis, Thomas Wiesner, Tatyana Milman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2017
Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profilesKlaus G Griewank, Thomas Wiesner, Rajmohan Murali, et al.
Pageof 8